Mekinist Trametinib 2 mg

DESCRIPTION

Mekinist is a kinase inhibitor indicated as a single agent which is used to treat patients who have a “BRAF” gene mutation. This medicine is also used to treat melanoma (skin cancer), non-small cell lung cancer, advanced or metastatic thyroid cancer that has spread and for  which there are no other treatment options. To buy Mekinist or to know its price contact 3S Corporation.

Manufacturer : Novartis Pharmaceuticals Corp

ADDITIONAL INFORMATION

Strengths available :  2 mg

Form :  Tablets

Dosage : Usual Adult Dose for Melanoma – Metastatic : Single agent: 2 mg orally once a day. Combination therapy: 2 mg orally once a day with dabrafenib. Duration of therapy: Until disease progression or unacceptable toxicity occurs.

Usual Adult Dose for Non-Small Cell Lung Cancer : 2 mg orally once a day with dabrafenib. Duration of therapy: Until disease progression or unacceptable toxicity occurs.

Usual Adult Dose for Thyroid Cancer : 2 mg orally once a day with dabrafenib. Duration of therapy: Until disease progression or unacceptable toxicity occurs.

Storage :  Once opened, the bottle may be stored for 30 days at not more than 30°C.

Is the medicine  FDA  approved : Yes

Date of Approval : April 30, 2018

SIDE EFFECTS

Common side effects are nausea, vomiting, diarrhea, loss of appetite, fever, chills, tiredness, bleeding, increased blood pressure, joint pain, cough, shortness of breath, swelling, rash or dry skin.

PACK SIZE

Pack of 30 tablets

Reviews

There are no reviews yet.

Be the first to review “Mekinist Trametinib 2 mg”

Your email address will not be published. Required fields are marked *